A-S Medication Solutions Medroxyprogesterone Acetate - Meningioma Claims

A-S Medication Solutions manufactures a generic version of medroxyprogesterone acetate injectable contraception, which is administered every three months for birth control. This contraceptive is effective.

There is a recent study that examined women who used medroxyprogesterone acetate injections, and found that users are 5.6 times more likely to develop meningioma, a brain tumor that often requires surgery.

A-S Medication Solutions is one of several companies manufacturing this generic drug. The appeal of dosing four times a year offers convenience to the public. Yet, long-term exposure may have harmed the patients.

Critical research findings about this medication

The 2024 BMJ study revealed many concerns about medroxyprogesterone acetate injections:

• Brain tumor risk increases with continued use
• Surgical intervention is often required for the resulting meningiomas
• The risk remains even after stopping the medication

A-S Medication Solutions' product info has focused on temporary side effects. It has missed a crucial safety concern that requires surgery.

Understanding your legal options

Did you get A-S Medication Solutions' injectable birth control? Did you then get diagnosed with a brain tumor? Our specialized team understands the complex medical evidence linking this medication to meningioma. Atraxia Law’s experience with pharmaceutical cases helps us vet claims based on:

• Documented injection history
• Medical diagnoses
• Treatment timeline
• Healthcare impact

We recognize that facing a brain tumor diagnosis changes everything. Let us help you understand your rights while you focus on your health. We check cases and connect clients with top dangerous drug attorneys.